Wealth Enhancement Advisory Services LLC Raises Holdings in Chemed Corporation $CHE

Wealth Enhancement Advisory Services LLC lifted its stake in Chemed Corporation (NYSE:CHE) by 79.5% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,289 shares of the company’s stock after acquiring an additional 1,900 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Chemed were worth $1,871,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Creekmur Asset Management LLC acquired a new position in Chemed during the 2nd quarter valued at approximately $28,000. First Horizon Corp purchased a new stake in shares of Chemed during the third quarter valued at $31,000. Parkside Financial Bank & Trust increased its position in shares of Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after acquiring an additional 44 shares during the period. HM Payson & Co. raised its stake in Chemed by 35.5% in the 3rd quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after acquiring an additional 27 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CHE shares. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Royal Bank Of Canada decreased their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Chemed presently has a consensus rating of “Moderate Buy” and a consensus target price of $555.50.

Chemed Stock Performance

Shares of Chemed stock opened at $427.00 on Friday. The firm has a 50-day simple moving average of $436.55 and a two-hundred day simple moving average of $442.46. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The company has a market cap of $6.05 billion, a P/E ratio of 22.58, a price-to-earnings-growth ratio of 2.09 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). The business had revenue of $624.90 million during the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. Chemed’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.64 EPS. Equities research analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s dividend payout ratio is presently 12.69%.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the sale, the chief executive officer owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This trade represents a 2.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.29% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.